NASDAQ: MDLN
Medline Inc Stock

$36.42-0.67 (-1.81%)
Updated Jun 17, 2026
MDLN Price
$36.42
Fair Value Price
$55.58
Market Cap
$47.84B
52 Week Low
$32.82
52 Week High
$50.88
P/E
N/A
P/B
4.24x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.75
Operating Cash Flow
N/A
Beta
0.51
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MDLN Overview

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MDLN's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
A
MDLN
Ranked
#28 of 42

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$8.75A
$21.22B
$14.86B
View Top Medical Stocks

Be the first to know about important MDLN news, forecast changes, insider trades & much more!

MDLN News

Overview

Due Diligence Score

Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MDLN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MDLN ($36.42) is undervalued by 34.47% relative to our estimate of its Fair Value price of $55.58 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MDLN ($36.42) is significantly undervalued by 34.47% relative to our estimate of its Fair Value price of $55.58 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MDLN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more MDLN due diligence checks available for Premium users.

Valuation

MDLN fair value

Fair Value of MDLN stock based on Discounted Cash Flow (DCF)

Price
$36.42
Fair Value
$55.58
Undervalued by
34.47%
MDLN ($36.42) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MDLN ($36.42) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

MDLN price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
40.78x
Market
12.4x

MDLN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.24x
Industry
3.11x
MDLN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MDLN's financial health

Profit margin

Revenue
$7.4B
Net Income
$129.0M
Profit Margin
1.8%

Assets to liabilities

Assets
$39.0B
Liabilities
$19.7B
Debt to equity
1.75
MDLN's short-term assets ($11.18B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MDLN's long-term liabilities ($17.13B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MDLN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$412.0M
Investing
-$96.0M
Financing
-$13.0M

MDLN vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MDLNC$47.84B-1.81%N/A4.24x
BDXC$39.02B-2.45%35.85x1.62x
ALCC$31.28B-2.58%38.41x1.41x
RMDC$27.02B-3.94%17.91x4.16x
WSTB$22.86B-1.82%43.03x7.64x

Medline Stock FAQ

What is Medline's quote symbol?

(NASDAQ: MDLN) Medline trades on the NASDAQ under the ticker symbol MDLN. Medline stock quotes can also be displayed as NASDAQ: MDLN.

If you're new to stock investing, here's how to buy Medline stock.

What is the 52 week high and low for Medline (NASDAQ: MDLN)?

(NASDAQ: MDLN) Medline's 52-week high was $50.88, and its 52-week low was $32.82. It is currently -28.41% from its 52-week high and 10.96% from its 52-week low.

How much is Medline's stock price per share?

(NASDAQ: MDLN) Medline stock price per share is $36.42 today (as of Jun 17, 2026).

What is Medline's Market Cap?

(NASDAQ: MDLN) Medline's market cap is $47.84B, as of Jun 18, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Medline's market cap is calculated by multiplying MDLN's current stock price of $36.42 by MDLN's total outstanding shares of 1,313,688,164.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.